ArticlePDF Available

Rift Valley fever: The Nigerian story

Authors:

Abstract

Rift Valley fever (RVF) is an arthropod-borne zoonotic disease of livestock. It is characterised by fever, salivation, abdominal pain, diarrhoea, mucopurulent to bloody nasal discharge, abortion, rapid decrease in milk production and death in animals. Infected humans experience an influenza-like illness that is characterised by fever, malaise, headaches, nausea and epigastric pain followed by recovery, although mortality can occur. RVF was thought to be a disease of sub-Saharan Africa but with the outbreaks in Egypt and the Arabian Peninsula, it may be extending its range further afield. Virological and serological evidence indicates that the virus exists in Nigeria and, with the warning signal sent by international organisations to countries in Africa about an impending outbreak, co-ordinated research between veterinarians and physicians in Nigeria is advocated.
VeterinariaItaliana,2011,47(1),3540
©IstitutoG.Caporale2011www.izs.it/vet_italianaVol.47(1),VetItal35
RiftValleyfever:theNigerianstory
AdewaleA.Adeyeye(1),PiusS.Ekong(2)&NicholasN.Pilau(1)
Summary
RiftValleyfever(RVF)isanarthropodborne
zoonoticdiseaseoflivestock.Itischaracterised
byfever,salivation,abdominalpain,diarrhoea,
mucopurulenttobloodynasaldischarge,
abortion,rapiddecreaseinmilkproduction
anddeathinanimals.Infectedhumans
experienceaninfluenzalikeillnessthatis
characterisedbyfever,malaise,headaches,
nauseaandepigastricpainfollowedby
recovery,althoughmortalitycanoccur.RVF
wasthoughttobeadiseaseofsubSaharan
AfricabutwiththeoutbreaksinEgyptandthe
ArabianPeninsula,itmaybeextendingits
rangefurtherafield.Virologicalandsero
logicalevidenceindicatesthatthevirusexists
inNigeriaand,withthewarningsignalsentby
internationalorganisationstocountriesin
Africaaboutanimpendingoutbreak,
coordinatedresearchbetweenveterinarians
andphysiciansinNigeriaisadvocated.
Keywords
Abortion,Africa,RiftValleyfever,Livestock
handlers,Nigeria,Publichealth,Virus,
Zoonosis.
Rapportosullafebbredella
ValledelRiftinNigeria
Riassunto
LafebbredellaValledelRift(RVF)èunamalattia
zoonosicadelbestiameveicolatadaartropodi.È
caratterizzatadafebbre,salivazione,dolore
addominale,diarrea,scolonasaledamucopurulento
aematico,aborto,rapidadiminuzionenella
produzionelatteaemorteneglianimali.Isoggetti
umaniinfettimanifestanounamalattiasimile
all’influenzacaratterizzatadafebbre,malessere,
attacchidicefalea,nauseaedoloreepigastrico
seguitidallaguarigione,sebbenepossaverificarsi
unamortalità.LaRVFeraritenutaunamalattia
dell’Africasubsahariana,maconifocolaiepidemici
inEgittoenellapenisolaarabicaèpossibilechestia
ampliandoancoradipiùilsuoraggio.L’evidenza
virologicaesierologicaindicacheilvirusèpresente
inNigeriaeconsistemadiallertainviatidalle
organizzazioniinternazionaliallenazioniafricane
riguardanteunimminentefocolaioepidemico,è
urgenteinquestopaeseunaricercacoordinatafra
veterinariemedici.
Parolechiave
Aborto,Addettialbestiame,Africa,Febbre
dellaValledelRift,Nigeria,Salutepubblica,
Virus,Zoonosi.
Introduction
RiftValleyfever(RVF)isalsoknownas
enzootichepatitisofsheepandcattle.Itisan
acute,infectiousandzoonoticdiseaseof
predominantlycattle,sheep,goat,camels,
Africanbuffalo(Synceruscaffer)andhumans.
Thediseaseiscausedbyanarbovirusandis
associatedwithperiodicoutbreaksthatmostly
occurontheAfricancontinent.Itisafebrile
diseasethatisaccompaniedbyabortionin
livestockandaseverefatalhaemorrhagic
syndromeinhumanshasbeenobserved(11).It
isanotifiablediseaseandisspreadbythebite
ofmosquitoes.
Thediseasewasfirstreportedamongsheepin
KenyabyMontgomeryin1912andStordyin
1913(4),butthediseasewasnotisolateduntil
1931(25).Presently,virologicalandserological
evidencesuggeststhatthevirusexists
(1) Department of Veterinary Medicine, Surgery and Theriogenology, Usmanu Danfodiyo University, P.M.B. 2254,
Sokoto, Nigeria
ayo4wale@hotmail.com
(2) Central Diagnostic Department, National Veterinary Research Institute, P.M.B. 01, Vom, Jos, Plateau State, Nigeria
AreportonRiftValleyfeverinNigeriaAdewaleA.Adeyeye,PiusS.Ekong&NicholasN.Pilau
36 Vol.47(1),VetItalwww.izs.it/vet_italiana©IstitutoG.Caporale2011
throughoutsubSaharanAfricaandMadagascar
and,inthelightofitsrecurrenceinEgyptin
1993and2003(5,7,9,39),itmaybeextending
itsrangeevenfurther.InSeptember2000,
casesofunexplainedhaemorrhagicfeverin
humansandassociatedanimaldeathsin
southwesternSaudiArabiaandYemenwere
confirmedasRVFand,bymidJanuary2001,
thediseasehadclaimedseveralhumanlivesin
thesecountries(1);theoutbreakonthe
ArabianPeninsularepresentsthefirstcasesof
RVFoutsideAfrica.In2007,anoutbreak
occurredinKenyaandSomaliawhereover
404humancases,including118deaths,were
reported(10).InSouthAfrica,thelastoutbreak
occurredinMay2010;preliminary
investigationrevealedthat186humanswere
confirmedRVFcasesoutofwhich18died(40).
Anoverviewofthediseaseisnecessarygiven
climatechangesthatfavourpossibleoutbreaks
(20,24)andthewarningsignalsdespatchedto
countriesinAfricabytheFoodand
AgricultureOrganizationandWorldHealth
Organization(16).
Aetiology
TheRVFvirusisthecausalagentofthe
disease.ThevirusisofthegenusPhlebovirus,
familyBunyaviridae(26).Itisanenveloped,
singlestrandednegativesenseRNAvirusthat
measuresbetween80nmand120nmin
diameterwiththreesegmentsnamedS(small),
M(medium)andL(large)(8).
Transmission
RVFisamosquitobornedisease(2).Aedesis
thespeciesofmosquitothatisincriminatedin
biologicaltransmission(36,37),although
Glossina,Culicoides,Culexspeciesandsandflies
mayplaylimitedrolesinbiologicaland
mechanicaltransmission(21,25).Apartfrom
thesevectors,thediseasehasbeenreportedto
spreadthroughneedleinoculation,contact
withinfectedanimalsorhumanswithhigh
prevalenceduringperiodsofheavyrainfall(2,
34,38,42).Experimentaltransmissioninsheep
frominfectedmouseserumhasbeenreported
(35).Riskgroupsincludeanimalhandlers,
particularlythoseassistinganimalsduring
abortions/parturition,thosetreatingsick
animalsandthosenursingaffectedpeople,
particularlyinareaswithoutbreaks(38).
Humansmaybeinfectedbydirectandindirect
contactwithinfectedanimalsaswellasby
bloodfromfoetusesorslaughteredanimals
(17).Transmissionisalsopossiblebymosquito
bite(6,25)andingestionofunpasteurisedor
uncookedmilkfrominfectedanimals(5,31).
Casesofverticaltransmissionhavealsobeen
reported(3,6).
Clinicalsigns
Theincubationperiodforthediseaseisshort.
Itrangesfrom1to6daysinanimals,although
itisshorterinyoungeranimals,andbetween4
to7daysinhumans(2,33).Inadultanimals,it
ischaracterisedbyfeverwithin24hof
infectionthatlastsbetween6and7daysbut
peaksbetweendays2and4postinfection;
viraemiacoincideswithfeverwhichpeakson
day3postinfection(29).Abortionsoccurin
pregnantanimalsandsigns,suchassalivation,
abdominalpain,diarrhoea,mucopurulentto
bloodynasaldischargeandrapiddecreasein
milkproductioninparticular,areobservedin
dairycows(2,25,35,41).Inyoungeranimals,
lambsandneonates,deathusuallyoccurs
within24hbutsignsoffever,depression,
anorexiaandabdominalpainareprominent
priortodeath(33).
Thediseaseinhumansisinfluenzalikeandis
characterisedbyfever,malaise,headache,
nausea,epigastricpain,sensationoffullness
overtheregionoftheliver,followedby
completerecovery.However,itmayevolve
intoahaemorrhagicfeversyndrome,meningo
encephalitisorevenaffecttheeyes(2,19,25,
32,33).
Animalsthatdieofthediseaseshowextensive
livernecrosisandenlargementatpostmortem
examination,withoedemaandhaemorrhages
onthewallofthegallbladder.Innewborn
lambsinfectedinutero,thecontentsofthe
abomasumandsmallintestineareofa
chocolatebrowncolour(8).Inaddition,the
lambwillexhibitgeneralisedhepaticnecrosis.
AdewaleA.Adeyeye,PiusS.Ekong&NicholasN.PilauAreportonRiftValleyfeverinNigeria
©IstitutoG.Caporale2011www.izs.it/vet_italianaVol.47(1),VetItal37
Diagnosis
Diagnosisisperformedbyisolatingand
identifyingthevirusorbyobservinga
fourfoldriseinspecificneutralisingantibody
titrebetweenacuteandconvalescentsera.
Uponpostmortemexamination,characteristic
histopathologicalfindingsoflivernecrosisin
allsusceptibleanimalsoftenprovidethefirst
cluetothedisease.Confirmatorydiagnosisis
byserologyusingIgMorIgGantibodyspecific
enzymelinkedimmunosorbentassay(ELISA),
complimentfixation,viralneutralisation,
haemagglutinationinhibitionandtheplaque
reductiontest.
Differentialdiagnosisinanimalsincludesthe
following:
bacterialsepticaemias
poisoning
rinderpest
pestedespetitsruminants(PPR)
bluetongue
bovineephemeralfever
enterotoxemiaofsheep
brucellosis
campylobacteriosis
toxoplasmosis
trichomoniasis
heartwater
otherabortificientcausalagents.
Epidemiology
RVFwasthoughtobeadiseaseofsubSaharan
Africa,butthediseasehasspreadtoEastand
CentralAfrica(14)andtowesternSaudi
ArabiaandYemen(25).Inadditiontocattle
andsheep,otheranimalshavebeenreported
tobesusceptibletothedisease.Antibodies
againstthediseasehavebeendetectedin
Africanbuffalo,blackrhino(Dicerosbicornis),
lesserkudu(Tragelaphusimberbis),impala
(Aepycerosmelampus),Africanelephant
(Loxodontaafricana),kongoni(Alcelaphus
buselaphuscokii),waterbuck(Kobusellipsiprymnus)
(11),goats,camelsandhorses(29)but
evidenceoftherolethattheseanimalsplayin
maintainingthevirusbetweenoutbreaksis
stillunknown.However,LaBeaudetal.(23)
reportedthatoldermaleslivinginrural
villagesandwhohaddisposedofanimal
abortuseswereresponsibleforinterepidemic
transmissioninKenya.
InNigeria,Fergusonfirstisolatedthevirus
fromanimals(15).Subsequentserological
evidencesuggeststhatthevirusmaybe
circulatingatlowlevelsindomesticlivestock
andinthehumanpopulation,particularly
amonglivestockworkersandwildliferangers
(28).Cattle,sheepgoatsandcamelsinthe
StatesofKadunaandSokotohaverevealed
significantantibodytitresintheirserum(12).
Serologicalprevalenceofthediseaseinthese
animalspeciesinIleIfeandIbadanwas
observedbyOlaleyeetal.(27)whoconfirmed
theexistenceofthediseaseinNigeria.Apart
fromtheseobservations,experimental
infectionwithdifferentstrainsofthediseasein
threeindigenousbreedsofsheepinNigeria,
namely:theWestAfricandwarf,Yankasaand
Oudahaveresultedinfataldisease(13).
Furtherstudiesarethereforerequiredto
determinethepresentstatusofthediseasein
Nigeria.
Treatment
Thereisnotreatmentforanimals,butaninitial
50mg/kgloadingdoseofribavirinfollowedby
10mg/kgat8hintervalfor9dayshasbeen
suggestedtocontributetothepreventionorto
providetherapyinhumans(30).
Preventionandcontrol
Preventionisbestachievedbyvaccination.A
liveattenuatedandkilledvaccineisavailable
forlivestock.TheliveattenuatedSmithburn
strainprovideslonglastingimmunitybutit
producesateratogeniceffectinsheepwhen
administeredinthefirsttrimester(22)anditis
abortogenicinpregnantewes(25).Apartfrom
these,thevaccinehasbeendocumented
experimentallynottoprotectagainstthe
NigeriaandLunyostrainsofthevirusinWest
Africandwarfsheep(35).Thelivevirus
vaccinesarerecommendedforuseinendemic
areas,whilethekilledvaccinesare
recommendedforuseoutsideendemicareas.
Aformalininactivatedvaccineissafefor
AreportonRiftValleyfeverinNigeriaAdewaleA.Adeyeye,PiusS.Ekong&NicholasN.Pilau
38 Vol.47(1),VetItalwww.izs.it/vet_italiana©IstitutoG.Caporale2011
pregnantewesbutprovidesonlyshortterm
immunityandhencerequiresabooster
inoculationtomaintaindurableimmunity.The
onlyvaccineclearedforhumanuseisthe
killedproductavailableonlyfromtheUnited
StatesArmyMedicalResearchandMaterial
Command(USAMRMC).Itisaninitialthree
doseseriesforprotectiveimmunitywith
annualboosterinoculationsrequiredto
maintainthatimmunity(25).Thisvaccinehas
beenusedtoelicitimmuneresponseamong
laboratorystaffinNigeria(18).
Vectorcontrolofmosquitopopulationsand
restrictedmovementsduringoutbreakscanbe
effectivemeasuressinceanimalshavehigh
levelsofviraemiaandconsequentlyamplify
transmission.Educationalcampaignsto
preventhumanexposuretoinfectedanimal
tissuesorabortusesandexposuretomosquito
vectorsareeffective.Vaccinationofpeoplein
highriskoccupationsisequallyeffectivein
combatinganoutbreak.
Conclusion
Inconclusion,RVFisemerginginnewareas
andthereissomereemergenceofthevirusin
previouslyaffectedareas.Hence,thereisa
strongneedfortheAfricancontinentto
strengthenregionalandnationalwarning
systems,suchascoordinatedresearch
betweenveterinariansandphysicians,which
willcontributetothepreventionofan
epidemic.
References
1. Abdo-Salem S., Gerbier G., Bonnet P., Al-Qadasi M., Tran A., Thiry E., Al-Eryni G. & Roger F. 2006.
Descriptive and spatial epidemiology of Rift Valley fever in Yemen 2000-2001. Ann NY Acad Sci,
1081, 240-242.
2. Abdulkadir I.A. 1989. Rift Valley fever. In Infectious diseases of livestock in Nigeria. Ahmadu Bello
University Press Limited, Zaria, 195-197.
3. Adam I. & Karsany M.S. 2008. Case report: Rift Valley fever with vertical transmission in a pregnant
Sudanese woman. J Med Virol, 80 (5), 929.
4. Anon. 2010. Rift Valley fever. RedGems (Re-Emergent Diseases Global Environment Monitoring from
Space) (www.redgems.org/spip.php?rubrique6 accessed on 30 December 2010).
5. Anon. 2010. Rift Valley fever (RVF): transmission to humans. East African Community (EAC), Health,
EAC Secretariat, Arusha (www.eac.int/health/index.php?option=com_content&view=article&id=
109%3Arift-valley-fever-rvf-transmissions-to-humans&catid=30%3Arvf&Itemid=33 accessed on
10 December 2010).
6. Arishi H.M., Aqeel A.Y. & Al-Hazmi M.M. 2006. Vertical transmission of fatal Rift Valley fever in a
newborn. Ann Trop Paediatr, 26 (3), 251-253.
7. Arthur R.R., El-Sharkawy M.S., Cope S.E., Bostros B.A., Oun S., Morrill J.C., Shope R.E., Hibbs R.G.,
Darwish M.A. & Imam I.Z. 1993. Recurrence of Rift Valley fever in Egypt. Lancet, 342 (8880), 1149-
1150.
8. Center for Infectious Disease Research & Policy (CIDRP) 2010. Rift Valley fever. CIDRP, University of
Minnesota, St Paul, Minnesota (www.cidrap.umn.edu/cidrap/content/biosecurity/ag-biosec/anim-
disease/rvf.html accessed on 10 December 2010).
9. Centers for Disease Control and Prevention (CDC) 1994. Rift Valley fever – Egypt, 1993. Morb Mortal
Wkly Rep, 43 (38), 693-700.
10. Centers for Disease Control and Prevention (CDC) 2007. Rift Valley fever outbreak – Kenya,
November 2006-January 2007. Morb Mortal Wkly Rep, 56 (4), 73-76.
11. Evans A., Gakuya F., Paweska J.T., Rostal M., Akoolo L., Van Vuren P.J., Manyibe T., Macharia J.M.,
Ksiazek T.G., Feikin D.R., Breiman R.F. & Kariuki Njenga M. 2008. Prevalence of antibodies against Rift
Valley fever virus in Kenyan wildlife. Epidemiol Infect, 136 (9), 1261-1269.
12. Ezeifeka G.O., Umoh J.U., Belino E.D. & Ezeokoli C.D. 1982. A serological survey for Rift Valley fever
antibodies in food animals in Kaduna and Sokoto States of Nigeria. Int J Zoonoses, 9 (2), 147-151.
13. Fagbami A.H., Tomori O., Fabiyi A. & Isoun T.T. 1975. Experimental Rift Valley fever in West African
dwarf sheep. Res Vet Sci, 18 (3), 334-335.
AdewaleA.Adeyeye,PiusS.Ekong&NicholasN.PilauAreportonRiftValleyfeverinNigeria
©IstitutoG.Caporale2011www.izs.it/vet_italianaVol.47(1),VetItal39
14. Faye O., Diallo M., Diop D., Bezeid O.E., Ba H., Niang M., Dia I., Mohammed S.A., Ndiaye K., Diallo D.,
Ly P.O., Diallo B., Nabeth P., Simon F., Lo B. & Diop O.M. 2007. Rift Valley fever outbreak with East
Central African virus lineage in Mauritania, 2003. Emerg Infect Dis, 13 (7), 1016-1023.
15. Ferguson W. 1959. Identification of Rift Valley fever in Nigeria. Bull Epiz Dis Afr, 7, 317-318.
16. Food and Agriculture Organization (FAO) 2008. Climate models predict increased risk of
precipitation in the Horn of Africa for the end of 2008. Empress Watch. FAO, Rome, 4 pp
(ftp://ftp.fao.org/docrep/fao/011/aj129e/aj129e00.pdf accessed on 3 November 2010).
17. Food and Agriculture Organization (FAO) 2010. Rift Valley fever: transmission and spread. Causes of
transmission. FAO, Rome (www.fao.org/docrep/006/y4611e/y4611e04.htm#TopOfPage accessed
on 10 December 2010).
18. Frank-Peterside N. 2000. Response of laboratory staff to vaccination with an inactivated Rift Valley
fever vaccine – TSI-GSD. Afr J Med Sci, 29 (2), 89-92.
19. Gerdes G.H. 2004. Rift Valley fever. Rev Sci Tech, 23 (2), 612-623.
20. Gould E.A. & Higgs S. 2009. Impact of climate change and other factors on emerging arbovirus
diseases. Trans R Soc Trop Med Hyg, 103 (2), 109-121.
21. Hoch A.L., Gargan T.P. & Bailey C.L. 1985. Mechanical transmission of Rift Valley fever virus by
hematophagous Diptera. Am J Trop Med Hyg, 34 (1), 188-193.
22. Hunter P., Erasmus B.J. & Vorster J.H. 2002. Teratogenicity of mutagenised Rift Valley fever virus
(MVP 12) in sheep. Onderstepoort J Vet Res, 69 (1), 95-98.
23. LaBeaud A.D., Muchiri E.M., Ndzovu M., Mwanje M.T., Muiruri S., Peters C.J. & King C.H. 2008.
Interepidemic Rift Valley fever seropositivity, northeastern Kenya. Emerg Infect Dis, 14 (8), 1240-1246.
24. Martin V., Chevalier V., Ceccato P., Anyamba A., De Simone L., Lubroth J., de La Rocque S. &
Domenech J. 2008. The impact of climate change on the epidemiology and control of Rift Valley
fever. Rev Sci Tech, 27 (2), 413-426.
25. Morrill J.C. 2001. Rift Valley fever in animals and humans. In Zoonoses, animal diseases that affect
man (D.E. Goodman, ed.). Christian Veterinary Missions, Seattle, 49-56.
26. Olaleye O.D., Baigent C.L., Mueller G., Tomori O. & Schmitz H. 1992. Electron microscopic
identification of Zinga virus as a strain of Rift Valley fever virus. Res Virol, 143 (3), 215-218.
27. Olaleye O.D., Tomori O., Fajimi J.L. & Schmitz H. 1996. Experimental infection of three Nigerian
breeds of sheep with the Zinga strain of the Rift Valley fever virus. Rev Elev Med Vet Pays Trop, 49 (1),
6-16.
28. Olaleye O.D., Tomori O., Ladipo M.A. & Schmitz H. 1996. Rift Valley fever in Nigeria: infections in
humans. Rev Sci Tech, 15 (3), 923-935.
29. Olaleye O.D., Tomori O. & Schmitz H. 1996. Rift Valley fever in Nigeria: infections in domestic animals.
Rev Sci Tech, 15 (3), 937-946.
30. Peters C.J., Reynolds J.A., Slone T.W., Jones D.E. & Stephen E.L. 1986. Prophylaxis of Rift Valley fever
with antiviral drugs, immune serum, an interferon inducer and a macrophage activator. Antiviral Res,
6 (5), 285-297.
31. Seifert H.S.H. 1996. Vector-borne diseases. In Tropical animal health, First Ed. Kluwer Academic
Publishers, Dordrecht, 246.
32. Shawky S. 2000. Rift Valley fever. Saudi Med J, 21 (12), 1109-1115.
33. Smith H.A., Jones T.C. & Hunt R.D. 1972. Diseases caused by viruses – Rift Valley fever. In Veterinary
pathology, 4th Ed. Lea and Febiger, Philadelphia, 471-474.
34. Thonnon J., Picquet M., Thiongane Y., Lo M., Sylla R. & Vercruysse J. 1999. Rift Valley fever
surveillance in the lower Senegal River basin: update 10 years after the epidemic. Trop Med Int
Health, 4 (8), 580-585.
35. Tomori O. 1979. Clinical, virological and serological response of the West African dwarf sheep to
experimental infection with different strains of Rift Valley fever virus. Res Vet Sci, 26 (2), 152-159.
36. Turell M.J., Presley S.M., Gad A.M., Cope S.E., Dohm D.J., Morrill J.C. & Arthur R.R. 1996. Vector
competence of Egyptian mosquitoes for Rift Valley fever virus. Am J Trop Med Hyg, 54 (2), 136-139.
37. Turell M.J., Linthicum K.J., Patrican L.A., Davies F.G., Kairo A. & Bailey C.L. 2008. Vector competence
of selected African mosquitoes (Diptera: Culicidae) species for Rift Valley fever virus. J Med Entomol,
45 (1), 102-108.
AreportonRiftValleyfeverinNigeriaAdewaleA.Adeyeye,PiusS.Ekong&NicholasN.Pilau
40 Vol.47(1),VetItalwww.izs.it/vet_italiana©IstitutoG.Caporale2011
38. Wilson M.L., Chapman L.E., Hall D.B., Dystra E.A., Ba K., Zeller H.G., Traoré-Lamina M., Henvy J.P.,
Linthicum K.J. & Peter C.J. 1994. Rift Valley fever in rural northern Senegal: human risk factors and
potential vectors. Am J Trop Med Hyg, 50 (6), 663-675.
39. World Health Organisation (WHO) 2003. Rift Valley fever in Egypt. WHO, Geneva (www.who.int/
csr/don/2003_09_02a/en/ accessed on 10 December 2010).
40. World Health Organisation (WHO) 2010 Rift Valley fever in South Africa – update 2, WHO, Geneva
(www.who.int/csr/don/2010_05_12/en/index.html accessed on 10 December 2010).
41. Yedloutschnig R.J., Dardiri A.H., Mebus. C.A. & Walker J.S. 1981. Abortion in vaccinated sheep and
cattle after challenge with Rift Valley fever virus. Onderstepoort J Vet Res, 69 (1), 95-98.
42. Zeller H.G., Fontenille D., Fontenille D., Traoré-Lamizana M., Thiongane Y. & Digoutte J.-P. 1997.
Enzootic activity of Rift Valley fever virus in Senegal. Am J Trop Med Hyg, 56 (3), 265-272.
... Rift Valley fever (RVF) is a viral illness that can cause mild to severe symptoms in humans and livestock. RVF is also known as enzootic hepatitis of sheep and cattle [1]. It is an acute, infectious and zoonotic disease of predominantly cattle, sheep, goats, camels, African buffalo (Syncerus caffer) and humans. ...
... It is a febrile disease that is accompanied by abortion in livestock and a severe fatal haemorrhagic syndrome in humans has been observed [2]. The disease was first reported among sheep in Kenya during an examination concerning a scourge among sheep on a ranch in the Rift Valley of Kenya by Montgomery in 1912 and Stordy in 1913 [1], but the disease was not isolated until 1931 [3]. From that moment forward, all incidents in Sub-Saharan Africa have been documented. ...
Article
Full-text available
Rift Valley Fever (RVF) is a viral zoonosis spread primarily by mosquitos that primarily affects livestock but has the potential to affect humans. Because of its potential to spread quickly and become an epidemic, it has become a public concern. In this article, the transmission dynamics of RVF with mosquito, livestock and human host using a compartmental model is studied and analyzed. The basic reproduction number R0 is computed using next generation matrix and the disease-free equilibrium state is found to be locally asymptotically stable if R0 < 1 which implies that rift valley fever could be put under control in a population where the reproduction number is less than 1. The numerical simulations give insightful results to further explore the dynamics of the disease based on the effect of three interventions; efficacy of vaccination, culling of livestock and trapping of mosquitoes introduced in the model
... Rift Valley fever (RVF) is an acute febrile disease of various species of animals (cattle, sheep, goats, and camels) including humans (zoonotic). The disease is also referred to as enzootic hepatitis of cattle and sheep (Adeyeye et al., 2011). The disease is an arthropod-borne disease caused by Rift Valley fever virus (RVFV) belonging to the family Bunyaviridae (Yousif et al., 2014). ...
Article
Full-text available
Over 90 years ago, precisely in 1931, Rift Valley fever (RVF) was discovered in Kenya. However, the virus spread to African countries including Sudan, Somalia, South Africa, Madagascar, Egypt, and Tanzania. It also spread to Saudi Arabia and Yemen. Rift Valley fever is an arthropod-borne viral zoonotic disease affecting various species of animals such as cattle, goats, sheep, camels, wild animals, and even humans. It is a highly infectious and contagious disease with quickly spread to other countries through the borders or international movements of animals. RVF is highly economical and of public health significance because it causes neonatal death and decreases milk production in animals, and it is associated with hemorrhagic fever, encephalitis, and ocular diseases in humans. Heavy and persistent rainfall, flooding, and availability of mosquito breeding sites such as lakes and water bodies around the animal herd influence the occurrence of RFV because mosquitoes especially Aedes and Culex serve as the primary vector of the disease. Humans become infected following contact with tissues, fluids, and infected animals. In animals, RVF is characterized by hemorrhagic fever, and abortion, while in humans it is associated with encephalitis, ocular diseases, and hemorrhagic fever. In this review article, we discussed the past and present seroprevalence study of Rift Valley in Nigeria then we forecast and suggested respective ways and methods to follow to prevent the future occurrence of the disease in Nigeria.
... Although it was first observed in 1912 and officially reported in 1930 around the Rift Valley area of Kenya [1,2], RVF has now spread to different parts of Africa and beyond [3] and is currently assuming a global dimension. The disease is caused by RVF virus (RVFV) which belongs to the order Bunyavirales, family Phenuiviridae and genus Phlebovirus [4]. ...
Article
Full-text available
Introduction: Rift Valley fever (RVF) is a zoonotic disease caused by RVF virus (RVFV) and transmitted primarily by mosquitoes and contact with fluids and tissues of infected animals. First described in Kenya, it has spread to many African countries and beyond. In humans, it is sometimes misdiagnosed because the symptoms resemble those of influenza and/or malaria. Butchers, abattoir workers, and livestock keepers have the highest risk of infection. Methodology: In this study, serum samples collected between February and September 2019 from 196 individuals comprising of butchers (n = 121), abattoir/slaughterhouse workers (n = 55), and livestock keepers (n = 20) in Benue, Sokoto, and Borno States of northern Nigeria were screened using a commercial ELISA that detected anti-RVFV IgM and IgG alike (i.e., without discrimination). Data from administered questionnaires and the ELISA results were statistically analyzed. Results: Thirty-nine (19.9%) of the 196 samples were positive for RVFV antibodies. The distribution by states showed that 17.4% (8/46), 21.7% (15/69), and 19.8% (16/81) of samples from Benue, Sokoto, and Borno States were seropositive, respectively. Additionally, 21.5% (26/121) butchers, 16.4% (9/55) abattoir workers, and 20% (4/20) livestock keepers were seropositive. Conclusions: These findings provide serological evidence for exposure of occupationally at-risk individuals in northern Nigeria to RVFV. The higher seropositivity obtained in Sokoto and Borno states could be due to contact of these individuals with infected animal blood/tissues, aborted fetuses, and unhindered transboundary movement of animals and animal products into these states which share international borders with Niger, Chad, and Cameroon where evidences of RVFV infections were recently reported.
... Moreover, in Nigeria, RVFV antibodies were detected in horses using a complement fixation test (Olaleye et al. 1989;Olaleye et al. 1996), and the virus was isolated in Nigeria from sheep around 1959; however, this wasn't related to an epizootic event (Adeyeye, Ekong & Pilau 2011), and serological results in this time that were obtained from zebras (Equus burchelli) were negative. This result may clarify that equine might not support RVFV. ...
Article
Full-text available
In this study, the serological surveillance of Rift Valley Fever virus (RVFV) in southern Egypt was carried out for 460 serum samples collected from domestic animals (unvaccinated), including cattle, sheep, goat, camel and donkey reared in three different provinces (Qena, Luxor and Aswan). Enzyme linked immunosorbent assay (ELISA) was used to detect RVFV antibodies. The results showed that 97 out of 460 animals were positive by using blocking ELISA. The percentage of RVFV infection in cattle, sheep, goat, camel and donkey was 5.55%, 65.21%, 14.44%, 20.65% and 0%, respectively. Geographical distribution and breeding system were taken into consideration for RVFV infection in these animals. The most prevalent type of infection was identified in intensive breeding farms systems (27.63%), and then in individual breeding systems (11.68%). Qena had a higher infection rate of RVFV (23.55%), in comparison to Aswan and Luxor (20.65% and 14.14%, respectively). Marked seroprevalence recorded in this study indicates a high incidence of infection in sheep (65.21%) and camel (20.65%); this necessitates the application of more effective strategies to control these types of infections in Egypt. This study provides a concise picture about the RVFV disease in southern Egypt. We need more similar studies targeted to clarify the reliable epidemiological status of RVFV disease in southern Egypt and other localities.
... Moreover, in Nigeria, RVFV antibodies were detected in horses using a complement fixation test (Olaleye et al. 1989;Olaleye et al. 1996), and the virus was isolated in Nigeria from sheep around 1959; however, this wasn't related to an epizootic event (Adeyeye, Ekong & Pilau 2011), and serological results in this time that were obtained from zebras (Equus burchelli) were negative. This result may clarify that equine might not support RVFV. ...
Article
Full-text available
In this study, the serological surveillance of Rift Valley Fever virus (RVFV) in southern Egypt was carried out for 460 serum samples collected from domestic animals (unvaccinated), including cattle, sheep, goat, camel and donkey reared in three different provinces (Qena, Luxor and Aswan). Enzyme linked immunosorbent assay (ELISA) was used to detect RVFV antibodies. The results showed that 97 out of 460 animals were positive by using blocking ELISA. The percentage of RVFV infection in cattle, sheep, goat, camel and donkey was 5.55%, 65.21%, 14.44%, 20.65% and 0%, respectively. Geographical distribution and breeding system were taken into consideration for RVFV infection in these animals. The most prevalent type of infection was identified in intensive breeding farms systems (27.63%), and then in individual breeding systems (11.68%). Qena had a higher infection rate of RVFV (23.55%), in comparison to Aswan and Luxor (20.65% and 14.14%, respectively). Marked seroprevalence recorded in this study indicates a high incidence of infection in sheep (65.21%) and camel (20.65%); this necessitates the application of more effective strategies to control these types of infections in Egypt. This study provides a concise picture about the RVFV disease in southern Egypt. We need more similar studies targeted to clarify the reliable epidemiological status of RVFV disease in southern Egypt and other localities.
... In Nigeria, there has been no report of outbreak of RVF among humans, but antibodies against the virus have been found in few studies in livestock and humans. The prevalence of the virus infection ranged from 0.7 to 14.8% in animals and humans, respectively (Opayele et al., 2019;Ezeifeka et al., 1982;Adeyeye et al., 2011;Olaleye et al., 1996;Tomori, 1980). Jos metropolis is characterized by conducive weather, good rainfall with pockets of forest, and good grazing fields for ruminants. ...
... Human infections have been documented repeatedly in Nigeria (Tomori, 1980;Tomori et al., 1988) and an IgM prevalence of 23.2 % indicated the likelihood of local circulation of RVFV (Olaleye et al., 1996b). The virus has been isolated from animals (Adeyeye et al., 2011) and antibodies have been detected in various animal populations, including horses (Olaleye et al., 1989;Olaleye et al., 1996c). ...
Article
Rift Valley fever phlebovirus (RVFV) is an arthropod-borne virus that has caused substantial epidemics throughout Africa and in the Arabian Peninsula. The virus can cause severe disease in livestock and humans and therefore the control and prevention of viral outbreaks is of utmost importance. The epidemiology of RVFV has some particular characteristics. Unexpected and significant epidemics have been observed in spatially and temporally divergent patterns across the African continent. Sudden epidemics in previously unaffected areas are followed by periods of long-term apparent absence of virus and sudden, unpredictable reoccurrence in disparate regions. Therefore, the elucidation of underlying mechanisms of viral maintenance is one of the largest gaps in the knowledge of RVFV ecology. It remains unknown whether the virus needs to be reintroduced before RVFV outbreaks can occur, or if unperceived viral circulation in local vertebrates or mosquitoes is sufficient for maintenance of the virus. To gain insight into these knowledge gaps, we here review existing data that describe potential mechanisms of RVFV maintenance, as well as molecular and serological studies in endemic and non-endemic areas that provide evidence of an inter- or pre-epidemic virus presence. Basic and country-specific mechanisms of RVFV introduction into non-endemic countries are summarized and an overview of studies using mathematical modeling of RVFV persistence is given.
... Epe is situated at the northeastern part of the serological evidences suggest the presence and circulation of equine encephalitis (Adeyefa et al., 1996), West Nile Fever (Olaleye et al., 1990Baba et al, 2013, Sule andOluwayelu, 2016;Sule et al., 2015 andAdesina et al., 2017) and Rift Valley Fever (Adeyeye et al., 2011;Tomori, 1980 andTomori et al., 1988) viruses in Nigeria. Lagos State has network of water drainage systems including canals and gutters constructed to drain surface water runoffs during heavy rainfall and to safely dispose effluents from various sources into the Lagos lagoon. ...
... [19] In Nigeria, there has been no official report of outbreak of RVF, but antibodies to the virus have been found in livestock and humans. [20][21][22] The prevalence of the virus infection ranged from 11.5 to 14.8% in animals and humans, respectively. [23,24] The virus is transmitted to humans and animals through bites of infected Aedes and Culex mosquitos. ...
Article
The risk of exposure of slaughterhouse workers to Rift Valley fever (RVF) virus-infected animals in Nigeria was assessed by determining the prevalence of anti-RVF IgM in cattle, goats and sheep slaughtered in a major abattoir in Ibadan, Nigeria. Blood samples were collected from 290 animals in Bodija Municipal abattoir, Ibadan, Nigeria in January and February 2017 and analyzed for the presence of RVF virus using IgM Enzyme-Linked Immunosorbent Assay (ELISA) and Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) for detection of the virus RNA. Descriptive statistics was used to analyze data. Overall, an IgM prevalence of 0.7% (2/290) was found among the blood samples of the animals, suggesting recent exposure to the virus. Antibody was detected in the sera from a cow and one goat. RVF virus RNA was not detected in the 2 IgM positive blood samples. There was no statistically significant relationship between RVF IgM infection and some variables of the animals, including age, sex and breed (p ≥ 0.05). Results of this study indicate active RVF virus transmission in domestic livestock in Nigeria. The study emphasizes the need to embark on monitoring of human and animal populations to prevent outbreak of the virus in the country.
Article
Full-text available
Introduction: The International Health Regulations 2005 require countries to establish laboratory systems for rapid and safe confirmation of public health emergencies including zoonoses. Objectives: This study assessed the national veterinary laboratory system capacity for the confirmation of infectious threats to global health security in Benin. Method: The study was descriptive, cross-sectional and evaluative. The non-probability sampling method with selection of the two existing veterinary laboratories were used. Two questionnaires, one observation grid and the Food and Agriculture Organization laboratory mapping tool-core were used. The system capacity was rated good if each laboratory met at least 80% of the assessed criteria. Otherwise, the capacity was rated insufficient. Results: The national veterinary laboratory system capacity in Benin was insufficient. Bohicon laboratory satisfied 27.2% of assessed criteria; With the laboratory mapping tool-core, Parakou laboratory had an average indicator of 50.7%. Laboratory collaboration and networking was the best performing domain with 66.7%. Only basic supplies category reached 80%. Laboratory budget, sample accession and availaible technology had the lowest scores. The veterinary laboratory system is facing shortage of staffs. Avian influenza virus is confirmed by the two laboratories; Bacillus anthracis and rift valley fever virus are only confirmed by Parakou laboratory. Ebola and Lassa fever are not confirmed. There is no collaboration between the laboratories in the country. Conclusion: The veterinary laboratories are not able to ensure timely detection of zoonoses and inform health system for preparedness. The development and implementation of the veterinary laboratory system improvement plan is essential for the global health security in Benin.
Article
Full-text available
Climate change is likely to change the frequency of extreme weather events, such as tropical cyclones, floods, droughts and hurricanes, and may destabilise and weaken the ecosystem services upon which human society depends. Climate change is also expected to affect animal, human and plant health via indirect pathways: it is likely that the geography of infectious diseases and pests will be altered, including the distribution of vector-borne diseases, such as Rift Valley fever, yellow fever, malaria and dengue, which are highly sensitive to climatic conditions. Extreme weather events might then create the necessary conditions for Rift Valley fever to expand its geographical range northwards and cross the Mediterranean and Arabian seas, with an unexpected impact on the animal and human health of newly affected countries. Strengthening global, regional and national early warning systems is crucial, as are co-ordinated research programmes and subsequent prevention and intervention measures.
Article
Full-text available
While some skeptics remain unconvinced that global climate change is a reality, there is no doubt that during the past 50 years or so, patterns of emerging arbovirus diseases have changed significantly. Can this be attributed to climate change? Climate is a major factor in determining: (1) the geographic and temporal distribution of arthropods; (2) characteristics of arthropod life cycles; (3) dispersal patterns of associated arboviruses; (4) the evolution of arboviruses; and (5) the efficiency with which they are transmitted from arthropods to vertebrate hosts. Thus, under the influence of increasing temperatures and rainfall through warming of the oceans, and alteration of the natural cycles that stabilise climate, one is inevitably drawn to the conclusion that arboviruses will continue to emerge in new regions. For example, we cannot ignore the unexpected but successful establishment of chikungunya fever in northern Italy, the sudden appearance of West Nile virus in North America, the increasing frequency of Rift Valley fever epidemics in the Arabian Peninsula, and very recently, the emergence of Bluetongue virus in northern Europe. In this brief review we ask the question, are these diseases emerging because of climate change or do other factors play an equal or even more important role in their emergence?
Article
Full-text available
Most outbreaks of Rift Valley fever (RVF) occur in remote locations after floods. To determine environmental risk factors and long-term sequelae of human RVF, we examined rates of previous Rift Valley fever virus (RVFV) exposure by age and location during an interepidemic period in 2006. In a randomized household cluster survey in 2 areas of Ijara District, Kenya, we examined 248 residents of 2 sublocations, Gumarey (village) and Sogan-Godud (town). Overall, the RVFV seropositivity rate was 13% according to immunoglobulin G ELISA; evidence of interepidemic RVFV transmission was detected. Increased seropositivity was found among older persons, those who were male, those who lived in the rural village (Gumarey), and those who had disposed of animal abortus. Rural Gumarey reported more mosquito and animal exposure than Sogan-Godud. Seropositive persons were more likely to have visual impairment and retinal lesions; other physical findings did not differ.
Article
Rift Valley fever (RVF) is an ecologically complex emerging arboviral disease that causes significant illness in both livestock and people. This review article is designed to assist the reader in understanding the varied aspects of RVF disease in animals and humans. The historical facets of RVF disease, including the evolution of human outbreaks, are presented and discussed. The different clinical presentations of human RVF disease and the underlying causes are then addressed. We explore the exposure and transmission potential of RVF in animals and people. In the concluding section, we discuss the historical role of RVF as a biological weapon. We conclude with an outline of the important unanswered questions for ongoing research into this important zoonotic disease.
Article
West African dwarf sheep were inoculated with three different strains of Rift Valley fever virus (RVFV). Using infective mouse serum as the source of virus classical RVFV disease characterised by sudden onset, a sharp but transient febrile response, viraemia, abortions and the development of specific RVFV antibodies in surviving animals was observed. The severity of clinical response was, however, dependent on the strain of virus used, with animals inoculated with Smithburn's neuroadapted strain showing a milder response than those inoculated with either the Nigerian or Lunyo strain. The inoculation of sheep with RVFV infective mouse brain material of the three different strains resulted in a mild febrile response with low level viraemia. Immune sera from sheep inoculated with both the Nigerian and Smithburn's neurotropic strains did not neutralise the Lunyo virus strain in a mouse intracerebral neutralisation test; the reverse, however, was not the case. The findings indicate that the West African dwarf sheep is highly susceptible to RVFV infection and that previous reports of only a mild clinical response following inoculation with the Nigerian strain were due to infective mouse brain rather than infective mouse serum.
Article
West African Dwarf sheep were challenged with a low mouse brain-passaged Rift Valley fever virus (Ib-AR 55172) isolated from Nigeria. Viraemia, mild febrile reaction and neutralising antibodies were demonstrated in inoculated animals.
Article
Electron microscopic examination of a negatively stained suspension of Zinga virus showed particles 90-100 nm in diameter, enveloped with spikes 12-20 nm in length and 5 nm in diameter. Further identification of the virus by immune electron microscopy showed the reactivity of human Rift Valley fever virus-positive serum with Zinga virus. Results of this study are in agreement with earlier reports that Zinga virus is a strain of Rift Valley fever virus.
Article
Rift Valley fever virus (RVFV), a member of the family Bunyaviridae, extended its range from sub-Saharan Africa into Egypt in 1977. Its clinical spectrum is recognized to include severe manifestations such as hemorrhagic fever and encephalitis. For these reasons, as well as the limited knowledge of specific therapy for Bunyaviridae infections, we investigated several prophylactic regimens for RVF in a mouse model. Rimantadine, thiosemicarbazone, and inosiplex were ineffective. Pretreatment with glucan was of some use, but the most encouraging results were obtained with the antiviral drug ribavirin, passive antibody, or an interferon inducer polyriboinosinic-polyribocytidylic acid complexed with poly-L-lysine and carboxymethylcellulose (poly[ICLC]). Ribavirin and poly(ICLC) were also shown to be efficacious in preventing disease in hamsters. Ribavirin (loading dose of 50 mg/kg followed by 10 mg/kg at 8-h intervals for 9 days) suppressed viremia in RVF-infected rhesus monkeys. Ribavirin also reduced virus yield in infected cell cultures; sensitivity varied markedly with cell type but not with virus strain. Immune mouse ascitic fluid, with a plaque reduction neutralization titer of 1:1024, was effective in a dose of 4 ml/kg, a volume approximately equivalent to administration of a unit of convalescent plasma to a human. Poly(ICLC) may well have functioned through interferon induction, since RVFV was shown to be sensitive to interferon in cell culture, and since another macrophage activator (glucan) was only marginally effective. These studies suggest that ribavirin, poly(ICLC), and convalescent plasma may have a role in prevention or therapy of human RVF.
Article
Experimental studies were conducted to determine if hematophagous Diptera were capable of mechanical transmission of Rift Valley fever (RVF) virus to laboratory animals. All species tested (Glossina morsitans, Aedes aegypti, Aedes taeniorhynchus, Culex pipiens, Stomoxys calcitrans, Lutzomyia longipalpis, and Culicoides variipennis) mechanically transmitted the virus to hamsters. Mechanical transmission rates for G. morsitans ranged from 0-100%, with the probability of mechanical transmission positively correlated with initial viremia titer and negatively correlated with the time after virus exposure. Mechanical transmission of RVF virus to lambs was demonstrated with both G. morsitans and Cx. pipiens. These findings demonstrated that mechanical transmission of RVF virus by hematophagous flies may contribute to the natural transmission and dissemination of this virus.